Yahoo

CRH (CRH) Completes Arcosa Deal, Is The Stock 31% Below Fair Value?

Explore stocks on Coinbase

CRH (NYSE:CRH) has completed its US$8.5b purchase of Arcosa, a major US aggregates and infrastructure supplier, in a deal that expands exposure to road, water, energy and data projects across the country.

CRH shares have been under pressure despite the Arcosa deal and an upcoming earnings update on 29 October 2026, with the share price down 32.86% year to date and total shareholder return still up strongly over three and five years.

Scan how CRH compares with other construction and infrastructure players under pressure this year by reviewing our curated list of 30 resilient stocks with low risk scores .

CRH now trades at a clear discount to both analyst targets and intrinsic estimates after the Arcosa purchase and regulatory concessions. Is that gap mispricing, or is it a fair reflection of higher execution and antitrust risk as the deal beds in?

Most Popular Narrative: 31% Undervalued

CRH closed at $84.89 against a narrative fair value of $122.72, so the current price embeds a sizeable discount before Arcosa and the Nordic deals are fully reflected.

The main thing that has to go right is that CRH continues to execute its aggregates-led acquisition and integration program, including Arcosa and Axius Water, so that expected scale benefits and margin improvements show up in cash generation over time.

Consistent delivery of acquisition synergies, including around 600 basis points of margin improvement on average within three years since 2018 and integration of Eco Material running ahead of original expectations, gives CRH room to translate future deals and efficiency programs into further operating margin expansion and earnings.

See why 31 investors see CRH as 31% undervalued .

Result: Fair Value of $122.72 (UNDERVALUED)

Still, the story breaks if US infrastructure funding slows, or if the Arcosa integration delivers weaker cash flow than analysts currently build into CRH forecasts.

Find out about the key risks to this CRH narrative .

Another View On CRH's Valuation

The first narrative leans on fair value estimates pointing to CRH being undervalued. On simple P/E maths, the picture is more mixed. The stock trades at 14.8x earnings, slightly richer than the Global Basic Materials group at 14.2x, yet well below a 21.2x fair ratio and a 26x peer average. That gap can signal room for rerating, or it can simply reflect extra balance sheet and execution risk. Which side do you think the market is pricing in?

To see how those earnings multiples tie back to the underlying numbers, have a look at the See what the numbers say about this price — find out in our valuation breakdown. .

NYSE:CRH P/E Ratio as at Oct 2026
NYSE:CRH P/E Ratio as at Oct 2026

Next Steps

Mixed messages in the CRH story, with both risks and rewards in play, make this a moment to dig into the data quickly, reach a personal view, and then weigh up the 5 key rewards and 1 important warning sign .

Looking for more CRH-sized investment ideas?

If CRH has sharpened your focus on valuation and risk, now is the moment to broaden your watchlist and actively hunt for your next opportunity.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CRH .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: